bishRNA-mRNA-AC

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NamebishRNA-mRNA-AC
Drug Alias Namebifunctional shRNA therapy-targeting acid ceramidase (Gradalis)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNA
Mechanisms of ActionAcid ceramidase inhibitorsN-Acylsphingosine Amidohydrolase 2 inhibitors
TargetsAcid ceramidaseN-Acylsphingosine Amidohydrolase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGradalis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGradalis Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A